Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) Shares Issued: 2021-2024

Historic Shares Issued for NewAmsterdam Pharma Co N.V (NAMS) over the last 4 years, with Dec 2024 value amounting to $13.8 million.

  • NewAmsterdam Pharma Co N.V's Shares Issued was N/A to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.3 million, marking a year-over-year change of. This contributed to the annual value of $13.8 million for FY2024, which is 59.60% up from last year.
  • Latest data reveals that NewAmsterdam Pharma Co N.V reported Shares Issued of $13.8 million as of FY2024, which was up 59.60% from $8.6 million recorded in FY2023.
  • NewAmsterdam Pharma Co N.V's Shares Issued's 5-year high stood at $234.6 million during FY2022, with a 5-year trough of $8.6 million in FY2023.
  • Moreover, its 3-year median value for Shares Issued was $13.8 million (2024), whereas its average is $85.7 million.
  • Its Shares Issued has fluctuated over the past 5 years, first soared by 176.96% in 2022, then plummeted by 96.32% in 2023.
  • Yearly analysis of 4 years shows NewAmsterdam Pharma Co N.V's Shares Issued stood at $84.7 million in 2021, then spiked by 176.96% to $234.6 million in 2022, then slumped by 96.32% to $8.6 million in 2023, then spiked by 59.60% to $13.8 million in 2024.